Pfizer’s application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Pfizer asked the FDA to authorize its Covid booster shots that target the BA.5 subvariant for ages 5 to 11, before clinical trial results have been published.
The company said its request is based on human data from a similar vaccine that targets the omicron BA.1 subvariant and data from animal studies on the BA.5 shots. Pfizer's application comes days after Moderna asked the FDA to authorize its omicron shots for kids ages 6 through 17. Pfizer on Monday asked the Food and Drug Administration to authorize its new Covid booster shots that target the omicron BA.5 subvariant for children ages 5 to 11.application to the FDA comes before clinical trial results of the new vaccines have been published. The company, in a statement, said its request is based on human data from a similar vaccine that targets the omicron BA.1 subvariant and data from animal studies on the BA.5 shots.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The FDA investigated the ongoing baby formula shortage. Here's what it found.The FDA has struggled managing baby formula shortages after bacteria was found in products. Experts weigh in on unresolved issues.
Read more »
Scientists: Eat More of This Carb – Even Supplements Make a Big DifferenceThe human gut evolved to thrive on fermentable fibers, not burgers. It might be daunting for customers to choose from the vast selection of dietary fiber supplements in the pharmacy or supermarket aisle. They also offer a variety of health claims without being subject to FDA approval or review. How
Read more »
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots?Do you need to stick with the same brand, or is it safe to mix it up?
Read more »
Pfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO Albert Bourla announced Saturday that he tested positive for COVID-19 — again.
Read more »